Phase
Condition
Menstruation
Memory Loss
Multiple Sclerosis
Treatment
N/AClinical Study ID
Ages > 16 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Female participants diagnosed with MS based on the 2024 McDonald Diagnostic criteria (biologically sex-based, any gender as long as not on hormonal gender-enhancingtherapy)
Aged 16 or older
Experiencing menstruation with cycles ranging from 21 to 35 days
Have entered menarche, still experiencing menstrual cycles, and have not yet enteredmenopause
May be using hormonal contraceptive methods (e.g., oral contraceptives or hormonalIUDs)
Able to speak English
Willing to provide informed consent (mature minors will be assessed by theirphysician for consent eligibility)
Able to complete questionnaires and operate the app
Exclusion
Exclusion Criteria:
- Diagnosed with CNS inflammation disorders other than MS, such as:
NMOSD (Neuromyelitis Optica Spectrum Disorder) or MOGAD (Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease)
Male or intersex individuals, given the inclusion criteria of requiring a uterus
Females under 15 years of age
Females who have not started menstruation
Females who have stopped menstruation due to menopause or hysterectomy
Pregnant or postpartum individuals within one year of delivery,
Individuals currently breastfeeding
Unable to provide informed consent, or not deemed a mature minor
Unable to complete questionnaires and operate the app
Study Design
Connect with a study center
University of Calgary
Calgary, Alberta
CanadaActive - Recruiting
University of Alberta
Edmonton, Alberta
CanadaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.